Breaking News Instant updates and real-time market news.

WWD

Woodward

$82.91 /

-2.4 (-2.81%)

16:07
06/09/20
06/09
16:07
06/09/20
16:07

Woodward upgraded to Overweight from Neutral at Alembic Global

Alembic Global analyst Peter Skibitski upgraded Woodward to Overweight from Neutral with a $117 price target.

WWD Woodward
$82.91 /

-2.4 (-2.81%)

06/01/20
Fly Intel: Top five analyst upgrades
06/01/20 Barclays
Barclays upgrades Woodward to Overweight on improved cash flow view
06/01/20 Barclays
Woodward upgraded to Overweight from Equal Weight at Barclays
04/13/20 BofA
Hexcel resumed with an Underperform at BofA

TODAY'S FREE FLY STORIES

Initiation
Innoviz Technologies initiated with a Neutral at Goldman Sachs » 19:49
04/18/21
04/18
19:49
04/18/21
19:49
INVZ

Innoviz Technologies

$10.13 /

+0.155 (+1.55%)

, VLDR

Velodyne Lidar

$13.38 /

+0.25 (+1.90%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

INVZ Innoviz Technologies
$10.13 /

+0.155 (+1.55%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

19:46 Today Goldman Sachs
Velodyne Lidar initiated with a Neutral at Goldman Sachs
03/30/21
Fly Intel: Top five analyst downgrades
03/30/21 Craig-Hallum
Velodyne downgraded to Hold at Craig-Hallum on lack of catalysts, Board drama
03/30/21 Craig-Hallum
Velodyne Lidar downgraded to Hold from Buy at Craig-Hallum
VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

INVZ Innoviz Technologies
$10.13 /

+0.155 (+1.55%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

Initiation
Velodyne Lidar initiated with a Neutral at Goldman Sachs » 19:46
04/18/21
04/18
19:46
04/18/21
19:46
VLDR

Velodyne Lidar

$13.38 /

+0.25 (+1.90%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

03/30/21
Fly Intel: Top five analyst downgrades
03/30/21 Craig-Hallum
Velodyne downgraded to Hold at Craig-Hallum on lack of catalysts, Board drama
03/30/21 Craig-Hallum
Velodyne Lidar downgraded to Hold from Buy at Craig-Hallum
03/24/21 UBS
Apple recently granted patent for LiDAR system, says UBS
VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

VLDR Velodyne Lidar
$13.38 /

+0.25 (+1.90%)

Upgrade
PT Indofood CBP upgraded to Buy from Neutral at Goldman Sachs » 19:40
04/18/21
04/18
19:40
04/18/21
19:40
PIFFY

PT Indofood CBP

$12.76 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital » 19:36
04/18/21
04/18
19:36
04/18/21
19:36
OMF

OneMain Holdings

$55.96 /

+0.73 (+1.32%)

, KKR

KKR

$53.29 /

+0.36 (+0.68%)

, APO

Apollo Global

$51.54 /

+1.27 (+2.53%)

, BEN

Franklin Resources

$30.05 /

-0.24 (-0.79%)

, VCTR

Victory Capital

$27.48 /

-0.25 (-0.90%)

, MS

Morgan Stanley

$78.58 /

-2.31 (-2.86%)

, GS

Goldman Sachs

$342.30 /

+3.71 (+1.10%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OMF OneMain Holdings
$55.96 /

+0.73 (+1.32%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

OMF OneMain Holdings
$55.96 /

+0.73 (+1.32%)

04/15/21 JPMorgan
OneMain Holdings price target lowered to $64 from $65 at JPMorgan
02/11/21 Piper Sandler
OneMain secondary creates buying opportunity, says Piper Sandler
02/10/21 Northland
OneMain Holdings price target raised to $60 from $45 at Northland
02/10/21 Citi
OneMain Holdings price target raised to $62 from $45 at Citi
KKR KKR
$53.29 /

+0.36 (+0.68%)

04/14/21 BMO Capital
KKR price target raised to $71 from $69 at BMO Capital
04/14/21 Credit Suisse
KKR price target raised to $60 from $53 at Credit Suisse
04/14/21 Deutsche Bank
KKR price target raised to $52 from $47 at Deutsche Bank
04/14/21 Citi
Citi boosts KKR target to $65, removes from US Focus List
APO Apollo Global
$51.54 /

+1.27 (+2.53%)

04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform from Perform at Oppenheimer
04/12/21 Wells Fargo
Apollo Global price target lowered to $57 from $62 at Wells Fargo
BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

04/09/21 Deutsche Bank
Franklin Resources price target raised to $29 from $26 at Deutsche Bank
03/29/21 BMO Capital
Franklin Resources upgraded to Outperform from Market Perform at BMO Capital
01/28/21
Invesco upgraded to Buy from Neutral at UBS
01/25/21 Barclays
Franklin Resources price target raised to $24 from $21 at Barclays
VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

04/09/21 BofA
Victory Capital double-upgraded to Buy from Underperform at BofA
04/09/21 BofA
Victory Capital upgraded to Buy from Underperform at BofA
11/19/20
Fly Intel: Top five analyst downgrades
11/19/20 BofA
Victory Capital double-downgraded to Underperform from Buy at BofA
MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

04/16/21 Wells Fargo
Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss
04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

04/16/21 BMO Capital
Goldman Sachs price target raised to $432 from $409 at BMO Capital
04/15/21 DA Davidson
Goldman Sachs price target raised to $378 from $347 at DA Davidson
04/15/21 Oppenheimer
Goldman Sachs price target raised to $497 from $468 at Oppenheimer
04/15/21 Credit Suisse
Goldman Sachs price target raised to $400 from $395 at Credit Suisse
OMF OneMain Holdings
$55.96 /

+0.73 (+1.32%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

  • 11
    Feb
  • 11
    Nov
KKR KKR
$53.29 /

+0.36 (+0.68%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

KKR KKR
$53.29 /

+0.36 (+0.68%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

APO Apollo Global
$51.54 /

+1.27 (+2.53%)

BEN Franklin Resources
$30.05 /

-0.24 (-0.79%)

VCTR Victory Capital
$27.48 /

-0.25 (-0.90%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

GS Goldman Sachs
$342.30 /

+3.71 (+1.10%)

Downgrade
Discover downgraded to Market Perform from Outperform at BMO Capital » 19:33
04/18/21
04/18
19:33
04/18/21
19:33
DFS

Discover

$102.29 /

+0.3 (+0.29%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DFS Discover
$102.29 /

+0.3 (+0.29%)

DFS Discover
$102.29 /

+0.3 (+0.29%)

04/16/21 Piper Sandler
Discover price target raised to $103 from $97 at Piper Sandler
04/08/21 Piper Sandler
Discover price target raised to $97 from $94 at Piper Sandler
03/17/21 Wedbush
LendingClub price target raised to $20.50 from $14 at Wedbush
03/15/21 Wells Fargo
Discover price target raised to $111 from $105 at Wells Fargo
DFS Discover
$102.29 /

+0.3 (+0.29%)

DFS Discover
$102.29 /

+0.3 (+0.29%)

DFS Discover
$102.29 /

+0.3 (+0.29%)

Periodicals
Fauci predicts resumption of J&J COVID vaccine use, Reuters reports » 17:55
04/18/21
04/18
17:55
04/18/21
17:55
JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

Anthony Fauci on Sunday…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

Periodicals
TSMC warns trade tensions may disrupt supply, Bloomberg reports » 17:48
04/18/21
04/18
17:48
04/18/21
17:48
TSM

TSMC

$118.84 /

+0.48 (+0.41%)

, AAPL

Apple

$134.15 /

-0.34 (-0.25%)

TSMC (TSM) warned for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSM TSMC
$118.84 /

+0.48 (+0.41%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

TSM TSMC
$118.84 /

+0.48 (+0.41%)

04/15/21 Argus
Lam Research price target raised to $725 from $625 at Argus
04/12/21
Fly Intel: Top five analyst initiations
04/12/21 Atlantic Equities
TSMC initiated with a Neutral at Atlantic Equities
04/01/21 DA Davidson
Onto Innovation price target raised to $80 from $75 at DA Davidson
AAPL Apple
$134.15 /

-0.34 (-0.25%)

04/14/21 Evercore ISI
Apple added to Tactical Outperform list at Evercore ISI
04/13/21 Wedbush
Facebook assumed with Neutral at Wedbush, cites privacy risk
04/12/21 Canaccord
Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem
04/09/21 Citi
Citi tells investors to focus on Apple's capital deployment, iPhone gains
TSM TSMC
$118.84 /

+0.48 (+0.41%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

TSM TSMC
$118.84 /

+0.48 (+0.41%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

TSM TSMC
$118.84 /

+0.48 (+0.41%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

TSM TSMC
$118.84 /

+0.48 (+0.41%)

AAPL Apple
$134.15 /

-0.34 (-0.25%)

Periodicals
Amazon cancels Lord of the Rings game announced two years ago, Bloomberg says » 17:40
04/18/21
04/18
17:40
04/18/21
17:40
AMZN

Amazon.com

$3,398.86 /

+20.63 (+0.61%)

, TCEHY

Tencent

$81.00 /

+1.02 (+1.28%)

Amazon's (AMZN)…

Amazon's (AMZN) embattled video game division has canceled an online role-playing game based on the fantasy series Lord of the Rings, which was announced in 2019, in another setback for the technology giant, Bloomberg's Jason Schreier reports. The game had been in development at Amazon Game Studios alongside the China-based Leyou Technologies. which was purchased by conglomerate Tencent (TCEHY) in December, the author notes. Reference Link

ShowHide Related Items >><<
TCEHY Tencent
$81.00 /

+1.02 (+1.28%)

AMZN Amazon.com
$3,398.86 /

+20.63 (+0.61%)

AMZN Amazon.com
$3,398.86 /

+20.63 (+0.61%)

04/13/21 Jefferies
Amazon sum-of-the-parts supports 'pathway to $5,700,' says Jefferies
04/12/21 Jefferies
Microsoft deal emphasizes healthcare cloud focus, says Jefferies
04/12/21 BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
04/05/21 Evercore ISI
Amazon.com assumed with an Outperform at Evercore ISI
TCEHY Tencent
$81.00 /

+1.02 (+1.28%)

03/22/21 Mizuho
Tencent price target raised to Rmb 710 from Rmb 600 at Mizuho
02/16/21 Barclays
Tencent price target raised to $115 from $89 at Barclays
01/26/21 KeyBanc
Tencent downgraded to Sector Weight on valuation at KeyBanc
01/26/21 KeyBanc
Tencent downgraded to Sector Weight from Overweight at KeyBanc
TCEHY Tencent
$81.00 /

+1.02 (+1.28%)

AMZN Amazon.com
$3,398.86 /

+20.63 (+0.61%)

TCEHY Tencent
$81.00 /

+1.02 (+1.28%)

AMZN Amazon.com
$3,398.86 /

+20.63 (+0.61%)

TCEHY Tencent
$81.00 /

+1.02 (+1.28%)

AMZN Amazon.com
$3,398.86 /

+20.63 (+0.61%)

AMZN Amazon.com
$3,398.86 /

+20.63 (+0.61%)

Periodicals
Japan, Pfizer agree on more vaccine supply, Bloomberg reports » 17:35
04/18/21
04/18
17:35
04/18/21
17:35
PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

Japan's vaccine czar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

Periodicals
Tesla crash in Texas believed to be driverless, WSJ reports » 17:31
04/18/21
04/18
17:31
04/18/21
17:31
TSLA

Tesla

$739.67 /

+0.98 (+0.13%)

Two men died after a…

Two men died after a Tesla vehicle that authorities believe was operating without anyone in the driver's seat crashed into a tree Saturday night north of Houston, The Wall Street Journal's Rebecca Elliott reports. One of the men was in the front passenger's seat and the other was in the back seat of the Tesla, which was traveling at high speed along a curve before it hit a tree around 11:25pm local time, Harris County Precinct 4 Constable Mark Herman said in an interview. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$739.67 /

+0.98 (+0.13%)

TSLA Tesla
$739.67 /

+0.98 (+0.13%)

04/13/21 Credit Suisse
Credit Suisse ahead of consensus into Q1 EPS for Tesla
04/12/21
Fly Intel: Top five analyst upgrades
04/12/21 Canaccord
Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem
04/12/21 Canaccord
Tesla upgraded to Buy from Hold at Canaccord
TSLA Tesla
$739.67 /

+0.98 (+0.13%)

TSLA Tesla
$739.67 /

+0.98 (+0.13%)

TSLA Tesla
$739.67 /

+0.98 (+0.13%)

TSLA Tesla
$739.67 /

+0.98 (+0.13%)

Conference/Events
Evogene to hold a virtual analyst and investor day » 17:24
04/18/21
04/18
17:24
04/18/21
17:24
EVGN

Evogene

$4.37 /

+0.0899 (+2.10%)

Virtual Analyst and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVGN Evogene
$4.37 /

+0.0899 (+2.10%)

EVGN Evogene
$4.37 /

+0.0899 (+2.10%)

11/30/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight
11/30/20 Cantor Fitzgerald
Evogene initiated with an Overweight at Cantor Fitzgerald
EVGN Evogene
$4.37 /

+0.0899 (+2.10%)

On The Fly
Box Office Battle: 'Godzilla vs. Kong' wins weekend with $7.7M » 17:23
04/18/21
04/18
17:23
04/18/21
17:23
T

AT&T

$29.95 /

+0.195 (+0.66%)

, CMCSA

Comcast

$55.11 /

+0.97 (+1.79%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, SNE

Sony

/

+

, LGF.A

Lionsgate

$16.04 /

+0.105 (+0.66%)

, LGF.B

Lionsgate

$13.68 /

+0.13 (+0.96%)

, DIS

Disney

$187.28 /

+1.42 (+0.76%)

, VIACA

ViacomCBS

$44.29 /

+1.24 (+2.88%)

, VIAC

ViacomCBS

$39.32 /

+0.11 (+0.28%)

"Box Office Battle" is…

ShowHide Related Items >><<
VIACA ViacomCBS
$44.29 /

+1.24 (+2.88%)

VIAC ViacomCBS
$39.32 /

+0.11 (+0.28%)

T AT&T
$29.95 /

+0.195 (+0.66%)

SNE Sony
/

+

LGF.B Lionsgate
$13.68 /

+0.13 (+0.96%)

LGF.A Lionsgate
$16.04 /

+0.105 (+0.66%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$55.11 /

+0.97 (+1.79%)

T AT&T
$29.95 /

+0.195 (+0.66%)

03/10/21 RBC Capital
Fortinet price target raised to $175 from $162 at RBC Capital
03/10/21 DA Davidson
Fortinet price target raised to $200 from $180 at DA Davidson
03/10/21 BTIG
Fortinet price target raised to $205 from $183 at BTIG
03/05/21 JPMorgan
JPMorgan sees AT&T rallying into analyst meeting, but not after
CMCSA Comcast
$55.11 /

+0.97 (+1.79%)

04/16/21
Fly Intel: Top five analyst upgrades
04/16/21 Raymond James
Comcast upgraded to Outperform from Market Perform at Raymond James
04/16/21 Raymond James
Comcast upgraded to Outperform from Market Perform at Raymond James
04/12/21 Pivotal Research
Comcast price target raised to $65 from $63 at Pivotal Research
CMCSK Comcast
$58.00 /

+ (+0.00%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
10/07/20 Benchmark
Benchmark would be 'aggressive buyer' of Comcast amid broader market weakness
09/22/20 Benchmark
Comcast price target raised to $60 from $54 at Benchmark
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
SNE Sony
/

+

04/09/21 Benchmark
Netflix deal for Sony films 'hardly transformative,' says Benchmark
03/08/21 Macquarie
Sony downgraded to Neutral from Outperform at Macquarie
03/08/21 BofA
BofA says buy AMD and Nvidia as Steam data points to GPU upgrade tailwinds
01/12/21 Citi
Sony PS5 sales to date 'steady but somewhat disappointing,' says Citi
LGF.A Lionsgate
$16.04 /

+0.105 (+0.66%)

02/08/21 Deutsche Bank
Lionsgate price target raised to $16 from $12 at Deutsche Bank
02/05/21 RBC Capital
Lionsgate price target raised to $13 from $7 at RBC Capital
01/28/21 Macquarie
Lionsgate price target raised to $18 from $12 at Macquarie
LGF.B Lionsgate
$13.68 /

+0.13 (+0.96%)

11/02/20 Morgan Stanley
Lionsgate assumed with an Equal Weight at Morgan Stanley
09/02/20 Barrington
Lionsgate price target raised to $14 from $10 at Barrington
05/05/20 Canaccord
Lionsgate price target lowered to $13 from $16 at Canaccord
DIS Disney
$187.28 /

+1.42 (+0.76%)

04/16/21 Truist
Disney price target raised to $205 from $195 at Truist
04/16/21 UBS
Disney checks show improving backdrop, says UBS
04/08/21 KeyBanc
Netflix, Disney superior retention reinforces scale advantages, says KeyBanc
03/29/21 Loop Capital
ViacomCBS upgraded to Hold at Loop Capital after share price decline
VIACA ViacomCBS
$44.29 /

+1.24 (+2.88%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
07/13/20
Fly Intel: Top five analyst initiations
07/13/20
Fly Intel: Top five analyst downgrades
VIAC ViacomCBS
$39.32 /

+0.11 (+0.28%)

04/07/21 Wolfe Research
Wolfe upgrades ViacomCBS to Outperform, sees 58% share upside
04/07/21 Wolfe Research
ViacomCBS upgraded to Outperform from Peer Perform at Wolfe Research
03/30/21
Fly Intel: Top five analyst upgrades
03/30/21 Gabelli
ViacomCBS upgraded to Buy from Hold at Gabelli
VIACA ViacomCBS
$44.29 /

+1.24 (+2.88%)

VIAC ViacomCBS
$39.32 /

+0.11 (+0.28%)

T AT&T
$29.95 /

+0.195 (+0.66%)

SNE Sony
/

+

LGF.A Lionsgate
$16.04 /

+0.105 (+0.66%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

CMCSA Comcast
$55.11 /

+0.97 (+1.79%)

  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
VIACA ViacomCBS
$44.29 /

+1.24 (+2.88%)

VIAC ViacomCBS
$39.32 /

+0.11 (+0.28%)

T AT&T
$29.95 /

+0.195 (+0.66%)

SNE Sony
/

+

LGF.A Lionsgate
$16.04 /

+0.105 (+0.66%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$55.11 /

+0.97 (+1.79%)

VIACA ViacomCBS
$44.29 /

+1.24 (+2.88%)

T AT&T
$29.95 /

+0.195 (+0.66%)

SNE Sony
/

+

LGF.A Lionsgate
$16.04 /

+0.105 (+0.66%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$55.11 /

+0.97 (+1.79%)

VIAC ViacomCBS
$39.32 /

+0.11 (+0.28%)

T AT&T
$29.95 /

+0.195 (+0.66%)

SNE Sony
/

+

DIS Disney
$187.28 /

+1.42 (+0.76%)

CMCSA Comcast
$55.11 /

+0.97 (+1.79%)

Conference/Events
Advance Auto Parts to hold a virtual meeting » 17:12
04/18/21
04/18
17:12
04/18/21
17:12
AAP

Advance Auto Parts

$192.78 /

+3.38 (+1.78%)

Analyst and Investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAP Advance Auto Parts
$192.78 /

+3.38 (+1.78%)

AAP Advance Auto Parts
$192.78 /

+3.38 (+1.78%)

04/16/21 Wedbush
Advance Auto Parts price target raised to $210 from $180 at Wedbush
03/26/21 Stephens
Advance Auto Parts price target raised to $180 from $175 at Stephens
03/17/21 Wells Fargo
Advance Auto Parts price target raised to $185 from $165 at Wells Fargo
03/17/21 UBS
Advance Auto Parts price target raised to $210 from $195 at UBS
AAP Advance Auto Parts
$192.78 /

+3.38 (+1.78%)

AAP Advance Auto Parts
$192.78 /

+3.38 (+1.78%)

Conference/Events
Morgan Stanley CRE analyst to hold an analyst/industry conference call » 16:46
04/18/21
04/18
16:46
04/18/21
16:46

Head of US CRE Research…

Head of US CRE Research Hill, along with James Woodwell, VP of Mortgage Bankers Association, discuss the state of the Commercial Real Estate Industry on an Analyst/Industry conference call to be held on April 19 at 1 pm.

Conference/Events
Morgan Stanley sustainability analyst holds analyst/industry conference call » 16:33
04/18/21
04/18
16:33
04/18/21
16:33

Global Head of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Morgan Stanley cross-asset strategists hold analyst/industry conference call » 16:30
04/18/21
04/18
16:30
04/18/21
16:30

Cross-Asset Strategist…

Cross-Asset Strategist Sheets, US and European Credit Strategist Sankaran, US IG and Credit Derivatives Strategist Patkar discuss is credit still an early cycle on an Analyst/Industry conference call to be held on April 19 at 9 am.

Upgrade
Sensata upgraded to Outperform from In Line at Evercore ISI » 16:27
04/18/21
04/18
16:27
04/18/21
16:27
ST

Sensata

$58.53 /

+0.14 (+0.24%)

Evercore ISI analyst Amit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ST Sensata
$58.53 /

+0.14 (+0.24%)

ST Sensata
$58.53 /

+0.14 (+0.24%)

04/15/21 Barclays
Sensata price target raised to $70 from $65 at Barclays
04/08/21 Morgan Stanley
NXP downgraded at Morgan Stanley with growth drivers priced in
03/22/21 Morgan Stanley
Sensata price target raised to $72 from $68 at Morgan Stanley
03/02/21 JPMorgan
Sensata upgraded to Overweight at JPMorgan on auto electrification/connectivity
ST Sensata
$58.53 /

+0.14 (+0.24%)

ST Sensata
$58.53 /

+0.14 (+0.24%)

Conference/Events
Jefferies alternative energy/solar analyst hold analyst/industry conference call » 16:13
04/18/21
04/18
16:13
04/18/21
16:13
SPWR

SunPower

$27.36 /

+0.92 (+3.48%)

, FSLR

First Solar

$80.15 /

+3.02 (+3.92%)

, RWE

Renewable Energy

/

+

Analysts, along with Cary…

Analysts, along with Cary Hayes, Americas President for REC Group, discuss the current state and outlook of the solar market, with a particular focus on solar modules on an Analyst/Industry conference call to be held on April 19 at 10 am.

ShowHide Related Items >><<
SPWR SunPower
$27.36 /

+0.92 (+3.48%)

FSLR First Solar
$80.15 /

+3.02 (+3.92%)

SPWR SunPower
$27.36 /

+0.92 (+3.48%)

03/22/21 Goldman Sachs
SunPower downgraded to Neutral from Buy at Goldman Sachs
03/16/21 Morgan Stanley
Morgan Stanley says proposed California rules 'skew negative' for rooftop solar
03/16/21 Barclays
SunPower price target raised to $28 from $17 at Barclays
03/09/21 Piper Sandler
SunPower price target lowered to $31 from $35 at Piper Sandler
FSLR First Solar
$80.15 /

+3.02 (+3.92%)

03/09/21 Piper Sandler
First Solar price target lowered to $81 from $92 at Piper Sandler
03/08/21
Fly Intel: Top five analyst upgrades
03/08/21 JPMorgan
First Solar price target lowered to $94 from $100 at JPMorgan
03/08/21 Credit Suisse
First Solar upgraded to Neutral from Underperform at Credit Suisse
RWE Renewable Energy
/

+

SPWR SunPower
$27.36 /

+0.92 (+3.48%)

FSLR First Solar
$80.15 /

+3.02 (+3.92%)

  • 15
    Dec
  • 17
    Sep
SPWR SunPower
$27.36 /

+0.92 (+3.48%)

SPWR SunPower
$27.36 /

+0.92 (+3.48%)

FSLR First Solar
$80.15 /

+3.02 (+3.92%)

SPWR SunPower
$27.36 /

+0.92 (+3.48%)

FSLR First Solar
$80.15 /

+3.02 (+3.92%)

Hot Stocks
Prothena presents Phase 1 study results of PRX004 » 16:12
04/18/21
04/18
16:12
04/18/21
16:12
PRTA

Prothena

$24.87 /

-0.835 (-3.25%)

Prothena presented…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTA Prothena
$24.87 /

-0.835 (-3.25%)

PRTA Prothena
$24.87 /

-0.835 (-3.25%)

03/15/21 Jefferies
Prothena price target raised to $38 from $30 at Jefferies
02/26/21 RBC Capital
Prothena upgraded to Outperform from Sector Perform at RBC Capital
02/26/21 RBC Capital
Prothena upgraded to Outperform from Sector Perform at RBC Capital
02/12/21 Jefferies
Jefferies upgrades 'very cheap' Prothena to Buy, doubles target to $30
PRTA Prothena
$24.87 /

-0.835 (-3.25%)

  • 24
    Mar
PRTA Prothena
$24.87 /

-0.835 (-3.25%)

Hot Stocks
Elbit Systems awarded $1.65B contract for flight training program » 16:10
04/18/21
04/18
16:10
04/18/21
16:10
ESLT

Elbit Systems

$143.14 /

+1.2 (+0.85%)

Elbit Systems announced,…

Elbit Systems announced, further to the company's announcement of January 5, 2021, that it was awarded a contract valued at approximately $1.65B for the establishment and operation of the International Flight Training Center of the Hellenic Air Force, as part of an agreement between the Israeli Ministry of Defense and the Hellenic Ministry of National Defense. The contract will be performed over a period of approximately 20 years and will include price indexation. Under the contract, Elbit Systems will supply new M-346 training aircraft and will maintain the entire training fleet, comprised of dozens of M-346 and T-6 training aircraft for a period of approximately 20 years. In addition, the company will provide its latest advanced Embedded Virtual Avionics onboard the training aircraft, deliver networked flight simulators and an array of Ground-Based Training Stations as well as a command and control systems to enable efficient management of the flight training operation.

ShowHide Related Items >><<
ESLT Elbit Systems
$143.14 /

+1.2 (+0.85%)

ESLT Elbit Systems
$143.14 /

+1.2 (+0.85%)

11/18/20 Jefferies
Elbit Systems downgraded to Hold on defense slowdown at Jefferies
11/18/20 Jefferies
Elbit Systems downgraded to Hold from Buy at Jefferies
Hot Stocks
CNH Industrial terminates On-Highway business discussions with FAW Jiefang » 16:08
04/18/21
04/18
16:08
04/18/21
16:08
CNHI

CNH Industrial

$15.98 /

+0.3 (+1.91%)

CNH Industrial has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNHI CNH Industrial
$15.98 /

+0.3 (+1.91%)

CNHI CNH Industrial
$15.98 /

+0.3 (+1.91%)

04/13/21 Deutsche Bank
CNH Industrial price target raised to $21 from $18 at Deutsche Bank
02/18/21 Citi
CNH Industrial resumed with a Buy at Citi
02/04/21 Vertical Research
CNH Industrial upgraded to Buy from Hold at Vertical Research
01/20/21 Vertical Research
CNH Industrial initiated with a Hold at Vertical Research
CNHI CNH Industrial
$15.98 /

+0.3 (+1.91%)

Hot Stocks
Amarin presents new analyses of EVAPORATE study » 16:06
04/18/21
04/18
16:06
04/18/21
16:06
AMRN

Amarin

$5.02 /

+0.01 (+0.20%)

Amarin announced that…

Amarin announced that further analyses from the Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: EVAPORATE Trial were presented as Late-Breaking Science at European Society of Cardiology Preventive Cardiology 2021, the Annual Congress of the European Association of Preventive Cardiology, on April 17. As previously reported and published in the European Heart Journal, VASCEPA demonstrated significant, 17% regression of low attenuation plaque volume on multidetector computed tomography compared with placebo over 18 months. The Effect of Icosapent Ethyl on Changes in Coronary Plaque Morphology: EVAPORATE analyses presented at ESC Preventive Cardiology 2021 demonstrated that with administration of 4 g/day of VASCEPA on top of statin therapy, there was an observed change in plaque stability occurring at 9 months and sustained through 18 months. Of the 80 patients that were enrolled in the randomized, double-blind, placebo-controlled EVAPORATE trial, 55 patients had images that were able to be utilized for the histology-validated software. The EVAPORATE plaque morphology study used ElucidVivo, the first FDA-cleared analysis for specific tissue characterization using histopathologic correlates to assess plaque morphology characteristics, including Lipid Rich Necrotic Core, fibrous cap thickness, and intraplaque hemorrhage. Whereas with placebo LRNC increased and cap thickness decreased, both indicative of moving to a less stable phenotype, with icosapent ethyl there was a measured LRNC decrease and cap thickness increase, indicative of moving to a more stable phenotype. The primary limitation of this single coronary plaque study as identified by its investigators is its small sample size. More study is needed to more fully understand the effects of VASCEPA on coronary plaque to determine the relationship, if any, of such plaque effects on cardiovascular risk reduction.

ShowHide Related Items >><<
AMRN Amarin
$5.02 /

+0.01 (+0.20%)

AMRN Amarin
$5.02 /

+0.01 (+0.20%)

04/12/21 Piper Sandler
New CEO at Amarin to facilitate continued growth, says Piper Sandler
04/06/21 Piper Sandler
Amarin 'one step closer' to multi-billion opportunity, says Piper Sandler
02/25/21 Piper Sandler
Amarin to have strong execution year ahead, says Piper Sandler
02/01/21 Piper Sandler
Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
AMRN Amarin
$5.02 /

+0.01 (+0.20%)

AMRN Amarin
$5.02 /

+0.01 (+0.20%)

AMRN Amarin
$5.02 /

+0.01 (+0.20%)

AMRN Amarin
$5.02 /

+0.01 (+0.20%)

Hot Stocks
Peloton refutes consumer product safety commission claims » 16:02
04/18/21
04/18
16:02
04/18/21
16:02
PTON

Peloton

$116.17 /

-3.77 (-3.14%)

In a statement, Peloton…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

04/07/21 KeyBanc
Peloton Bike OTD times improving further, says KeyBanc
04/06/21 Credit Suisse
Peloton initiated with an Outperform at Credit Suisse
04/05/21 Evercore ISI
Peloton assumed at In Line from Outperform at Evercore ISI
03/31/21 Wolfe Research
Peloton initiated with a Peer Perform at Wolfe Research
PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

Hot Stocks
Avadel presents new data from pivotal REST-ON Phase 3 trial of FT218 » 15:59
04/18/21
04/18
15:59
04/18/21
15:59
AVDL

Avadel Pharmaceuticals

$8.65 /

+0.09 (+1.05%)

Avadel Pharmaceuticals…

Avadel Pharmaceuticals announced the presentation of positive secondary endpoint data at the 2021 American Academy of Neurology Annual Meeting being held virtually from April 17-22, 2021. FT218 is currently under review at the U.S. Food and Drug Administration with a Prescription Drug User Fee Act target date of October 15, 2021. FT218 demonstrated significant consolidation of sleep on polysomnography for the 6 g dose at Week 3, the 7.5 g dose at Week 8, and 9 g dose at Week 13 compared to placebo. Data from the randomized, double-blind, placebo-controlled, multicenter, parallel-group study showed that the mean difference between FT218 and placebo for disturbed nocturnal sleep was statistically significant at all doses tested. FT218 was generally well tolerated, and the most common adverse reactions were well-known and established sodium oxybate adverse reactions. Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients with Narcolepsy: Additionally, FT218 demonstrated significant improvement in the Epworth Sleepiness Scale versus placebo at all doses tested. FT218 showed a statistically significant improvement compared to placebo at all doses tested for sleep quality and refreshing nature of sleep on a visual analogue scale, and for sleep paralysis on a sleep symptom diary. FT218 did not demonstrate significant improvement for hypnagogic compared to placebo. Adverse events were similar to the known sodium oxybate safety profile.

ShowHide Related Items >><<
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

  • 29
    Apr
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

On The Fly
On the Fly: The Week in SPAC News » 07:45
04/18/21
04/18
07:45
04/18/21
07:45
AGC

Altimeter Growth

$12.55 /

-0.95 (-7.04%)

, GRAB

Grab

/

+

, CHFW

Consonance-HFW Acquisition

$9.91 /

+0.055 (+0.56%)

, DEH

D8 Holdings Corp.

$9.97 /

-0.08 (-0.80%)

, RBOT

Computer Motion Inc

/

+

, DNZ

D and Z Media Acquisition

$9.86 /

-0.085 (-0.85%)

, ICE

IntercontinentalExchange

$120.73 /

+0.86 (+0.72%)

, TCVA

TCV Acquisition

$10.30 /

-0.2 (-1.90%)

, YTPG

TPG Pace Beneficial II

$10.13 /

+0.02 (+0.20%)

In SPAC news this week,…

ShowHide Related Items >><<
ICE IntercontinentalExchange
$120.73 /

+0.86 (+0.72%)

DEH D8 Holdings Corp.
$9.97 /

-0.08 (-0.80%)

CHFW Consonance-HFW Acquisition
$9.91 /

+0.055 (+0.56%)

AGC Altimeter Growth
$12.55 /

-0.95 (-7.04%)

AGC Altimeter Growth
$12.55 /

-0.95 (-7.04%)

GRAB Grab
/

+

CHFW Consonance-HFW Acquisition
$9.91 /

+0.055 (+0.56%)

DEH D8 Holdings Corp.
$9.97 /

-0.08 (-0.80%)

RBOT Computer Motion Inc
/

+

DNZ D and Z Media Acquisition
$9.86 /

-0.085 (-0.85%)

ICE IntercontinentalExchange
$120.73 /

+0.86 (+0.72%)

04/06/21 Raymond James
IntercontinentalExchange price target raised to $136 at Raymond James
01/12/21 Barclays
IntercontinentalExchange price target raised to $134 from $125 at Barclays
01/07/21 Piper Sandler
IntercontinentalExchange price target raised to $127 from $117 at Piper Sandler
12/22/20 Compass Point
IntercontinentalExchange price target raised to $125 from $110 at Compass Point
TCVA TCV Acquisition
$10.30 /

-0.2 (-1.90%)

YTPG TPG Pace Beneficial II
$10.13 /

+0.02 (+0.20%)

ICE IntercontinentalExchange
$120.73 /

+0.86 (+0.72%)

  • 05
    Nov
  • 10
    Sep
ICE IntercontinentalExchange
$120.73 /

+0.86 (+0.72%)

DNZ D and Z Media Acquisition
$9.86 /

-0.085 (-0.85%)

AGC Altimeter Growth
$12.55 /

-0.95 (-7.04%)

ICE IntercontinentalExchange
$120.73 /

+0.86 (+0.72%)

DNZ D and Z Media Acquisition
$9.86 /

-0.085 (-0.85%)

CHFW Consonance-HFW Acquisition
$9.91 /

+0.055 (+0.56%)

AGC Altimeter Growth
$12.55 /

-0.95 (-7.04%)

AGC Altimeter Growth
$12.55 /

-0.95 (-7.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.